Skip to main content

View full-text article in PMC

. 2014 Mar 10;9(3):e91028. doi: 10.1371/journal.pone.0091028

Table 3. Gender-related incidence of adverse drug reactions (ADR).

	Men number of ADR events, (%)	Women number of ADR events, (%)	RR¹	95% CI²
*All ADRs*	482 (95.6%)	497 (98.0%)	2.27^*	1.06, 4.84
*Zidovudine- related*	229 (47.5%)	279 (56.1%)	1.41^*	1.09, 1.82
*Stavudine-related*	37 (7.7%)	40 (8.0%)	1.05	0.66, 1.68
*Nevirapine-related*	59 (11.9%)	84 (17.4%)	1.56^*	1.10, 2.22
*Efavirenz-related*	43 (8.9%)	36 (7.2%)	0.80	0.50, 1.27

¹

RR: Relative Risk;

²

CI: Confidence Interval.

*significant risk.